Evidence map›Paper›PMID 34795412›Full record

ArticleActa pharmacologica Sinica2022

Catalpol improves impaired neurovascular unit in ischemic stroke rats via enhancing VEGF-PI3K/AKT and VEGF-MEK1/2/ERK1/2 signaling.

Hong-Jin Wang, Hai-Feng Ran, Yue Yin, Xiao-Gang Xu, Bao-Xiang Jiang, Shi-Qi Yu, Yi-Jin Chen, Hui-Jing Ren, Shan Feng, Ji-Fen Zhang and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Advances in three-dimensional modeling of ischemic injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Hong-Jin WangCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Hai-Feng RanCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Yue YinCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Xiao-Gang XuCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Bao-Xiang JiangCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Shi-Qi YuCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Yi-Jin ChenCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Hui-Jing RenCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Shan FengCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Ji-Fen ZhangCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Yi ChenCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China.
Qiang XueChongqing Medical and Pharmaceutical College, Chongqing, 401331, China. ygzxq3@sina.com.
Xiao-Yu XuCollege of Pharmaceutical Sciences & Chinese Medicine, Southwest University, Chongqing, 400715, China. xuxiaoyu@swu.edu.cn.
Southwest University · CNState Administration of Traditional Chinese Medicine of the People's Republic of China · CNChongqing Medical and Pharmaceutical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurovascular unit (NVU) is organized multi-cellular and multi-component networks that are essential for brain health and brain homeostasis maintaining. Neurovascular unit dysfunction is the central pathogenesis process of ischemic stroke. Thus integrated protection of NVU holds great therapeutic potential for ischemic stroke. Catalpol, classified into the iridoid monosaccharide glycoside, is the main active ingredient of the radix from traditional Chinese medicine, Rehmannia glutinosa Libosch, that exhibits protective effects in several brain-related diseases. In the present study, we investigated whether catalpol exerted protective effects for NVU in ischemic stroke and the underlying mechanisms. MCAO rats were administered catalpol (2.5, 5.0, 10.0 mg·kg

Indexed as

Ischemic StrokeVascular Endothelial Growth Factor AAnimalsIridoid GlucosidesMAP Kinase Signaling SystemPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatscatalpolIridoid GlucosidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor Acatalpolischemic strokeMEK1/2/ERK1/2neurovascular unit (NVU)PI3K/AKTVEGF

Identifiers

PMID34795412
PMCPMC9253350
OpenAlexW3212688719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.